验证使用患者衍生器官的CRC组合治疗策略的挑战
Valentin Benboubker1,2,3, George M Ramzy1,2,3,4, Sacha Jacobs1,2,3
1Molecular Pharmacology Group, School of Pharmaceutical Sciences, University of Geneva, 1 Rue Michel-Servet, Geneva, 4 1211, Switzerland.
Journal of experimental & clinical cancer research : CR
|September 11, 2024
概括
患者衍生器官 (PDO) 是癌症药物查的有价值的体外模型. 本综述探讨了它们在预测组合疗法的有效性和推进结直肠癌 (CRC) 个性化药物的使用.
科学领域:
- 在瘤学瘤学.
- 翻译医学是一种翻译医学.
- 生物技术是生物技术.
背景情况:
- 患者衍生器官 (PDO) 是从患者瘤中获得的已建立的ex vivo模型.
- PDO与原始瘤具有表型和基因型相似性,补充了其他癌症模型.
- 对于PDO对组合治疗反应的预测潜力尚未完全理解.
研究的目的:
- 审查PDO在验证和优化针对个性化结直肠癌 (CRC) 治疗的多药组合中的应用.
- 通过结合多种细胞类型来讨论创建更复杂的PDO模型的进展.
- 探索先进的PDO如何为个性化医学,特别是免疫疗法做出贡献.
主要方法:
- 对癌症研究中患者衍生器官的现有文献的综述.
- 分析近期在PDO模型开发和细胞类型丰富方面的进展.
- 讨论PDO在CRC的组合治疗和免疫治疗中的应用.
主要成果:
- 在查和验证癌症候选药物方面,PDO显示出前景.
- 用多种细胞类型丰富PDO可以改善它们的体内仿真.
- PDO越来越多地用于预测对组合疗法的敏感性.
结论:
- 来自患者的器官对推进CRC个性化医学的发展至关重要.
- 复杂的PDO模型正在缩小对有效免疫疗法策略的差距.
- 需要进一步的研究来克服挑战,并充分发挥PDO的潜力.
相关概念视频
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...